Compositions and methods for effecting glucoreduction
AssigneeJ. Uriach y Cia, S.A.
InventorAntonio C. Marin Moga
Life of this patent
Estimating the term…
Abstract
The invention relates to the use of the compound N-[4-beta-(o-anisamide-ethyl)-benzenesulphonyl]-N'-cyclopentylcarbamide and pharmaceutically acceptable salts thereof as well as compositions therewith plus a pharmaceutical carrier to effect glucoreduction activity, that is lowering of blood sugar levels, with reduced possibility of platelet aggregation and therefore of myocardial infarction.
Claims4
Method of effecting glucoreduction in a patient requiring the same, which comprises administering to such patient a glucoreduction effective amount of N-[4-beta-(o-anisamide-ethyl)-benzenesulphonyl]-N'-cyclopentylcarbamide or a pharmaceutically acceptable salt thereof.
Composition for achieving glucoreduction, comprising a pharmaceutical carrier and a glucoreduction effective amount of N-[4-beta-(o-anisamide-ethyl)-benzenesulphonyl]-N'-cyclopentylcarbamide or a pharmaceutically acceptable salt thereof.
Dependencies are inferred from the claim text.